Anteris Technologies Ltd
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AMEUF research report →
Companywww.anteristech.com
Anteris Technologies Ltd operates as a structural heart company. It manufactures and sells ADAPT, a regenerative tissue product. The company also engages in the developing of DurAVRTM, a 3D single piece aortic valve for the treatment of aortic stenosis.
- CEO
- Wayne Geoffrey Paterson
- IPO
- 2013
- HQ
- Toowong, QLD, AU
Price Chart
Valuation
- Market Cap
- $120.50M
- P/E
- -3.43
- P/S
- 172.41
- P/B
- -3476.49
- EV/EBITDA
- -3.45
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 70.26%
- Op Margin
- -4908.21%
- Net Margin
- -4921.28%
- ROE
- -774.43%
- ROIC
- -4256.30%
Growth & Income
- Revenue
- $4.37M · 8.83%
- Net Income
- $-123,263,368 · -83.06%
- EPS
- $-6.09 · -41.30%
- Op Income
- $-126,625,640
- FCF YoY
- -86.58%
Performance & Tape
- 52W High
- $15.53
- 52W Low
- $5.55
- 50D MA
- $7.00
- 200D MA
- $10.64
- Beta
- 0.75
- Avg Volume
- 2.18K
Get TickerSpark's AI analysis on AMEUF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our AMEUF Coverage
We haven't published any research on AMEUF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate AMEUF Report →